BusinessBiotagenics Partners with University of Ottawa and CHEO on a $9.1 Million Project with Genome Canada to Develop Therapies for Inflammatory Bowel DiseaseBy Nasdaq OMXJan 31, 2018, 12:30 PM UTC
BusinessTempus and NYU School of Medicine Announce New Initiative to Help Improve Outcomes for Pancreatic Cancer PatientsBy Nasdaq OMXJan 25, 2018, 3:30 PM UTC
BusinessTreos Bio Announces FDA Approval of IND of Its First PolyPEPI™ Precision Cancer Vaccine for Metastatic Colorectal CancerBy Nasdaq OMXJan 24, 2018, 1:15 PM UTC
BusinessARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical TrialBy Nasdaq OMXJan 8, 2018, 1:31 PM UTC
BusinessARCA Biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic TargetingBy Nasdaq OMXNov 16, 2017, 1:30 PM UTC
BusinessTempus and Sanford Health Collaborate on Personalized Medicine InitiativeBy Nasdaq OMXNov 1, 2017, 2:15 PM UTC
BusinessTempus Unveils Tempus xT, 595 Gene Panel Aimed at Empowering Data-Driven Cancer CareBy Nasdaq OMXOct 19, 2017, 2:30 PM UTC
